Clinical Trial Update: Methylprednisolone for Stroke With Large Infarct Core and Post-stroke Lymphocytopenia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating methylprednisolone for stroke patients with large infarct cores and post-stroke lymphocytopenia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-stroke Lymphocytopenia
• Stroke

Drugs mentioned

• METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: YiLin | Conditions: Large Infarct Core, Post-stroke Lymphocytopenia | Phase 3 | Status: RECRUITING